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Undifferentiated embryonal sarcoma of the liver (UESL) in adults, especially over 30 years old, is quite rare. We
report two adult UESL patients that one of them survived 62 months and one is now surviving more than 65
months treated with repeated hepatic resections and radio-frequency ablations. Although UESL is an entirely
unusual and aggressive tumor, multidisciplinary treatments including repeated hepatic resections and radio-
frequency ablations may provide a longer survival.
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Undifferentiated embryonal sarcoma of the liver (UESL)
is a rare malignant tumor commonly observed in chil-
dren [1]. UESL in adults, especially more than 30 years
old, is entirely uncommon [2, 3]. Because of its infre-
quency, treatment strategy of UESL in adult is not well
established [3, 4]. We have reported short-term out-
comes of two adult patients of UESL treated with hep-
atic resection separately in Japanese literatures [5, 6]. In
one of those reports, we emphasized that the patient
was successfully treated with a major hepatic resection
even for the huge tumor with congestion of three hep-
atic veins and inferior vena cava [5]. The other reported
the pathological feature of the case of UESL [6]. We
herein report the long-term outcomes of two cases of
adult UESL treated with multiple courses of hepatic re-
sections and radio-frequency ablations (RFAs) for the re-
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Case 1
A 52-year-old female was admitted to the hospital to
treat a huge liver tumor with complaints of dyspnea, se-
vere abdominal distension, and lower-extremity edema.
Hepatitis B virus surface antigen (HBs-Ag) and hepatitis
C virus antibody (HCV-Ab) were negative. The serum
level of DUPAN-II was 810 U/ml and that of CA125 was
157 IU/ml, and alpha-fetoprotein (AFP), protein induced
by vitamin K absence (PIVKA-II), carcinoembryonic
antigen (CEA), and carbohydrate antigen 19–9 (CA19-9)
were in the normal range. Computed tomography (CT)
showed a huge low-density tumor with a clear margin,
23 cm in diameter, and showed little enhancement after
administration of contrast medium (Fig. 1a). Magnetic
resonance (MR) imaging demonstrated the multicystic
tumor to be hypointense on T1-weighted images (Fig. 1b)
and hyperintense on T2-weighted images (Fig. 1c). A
right tri-sectionectomy as the first operation was per-
formed safely and successfully, even though the tumor
entirely compressed the inferior vena cava and the root
of three hepatic veins. Operation time was 13 h and in-
traoperative bleeding was 2400 g. Resected specimen
showed a heterogenic tumor sized 23 × 22 × 11 cm
(Fig. 1d). Histologically, spindled, oval, or stellate tumorrticle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Fig. 1 Computed tomography showed a huge low-density tumor sized 17 cm in diameter that showed little enhancement (a). Magnetic
resonance imaging showed a multicystic tumor to be hypointense on T1-weighted images (b) and hyperintense on T2-weighted images (c).
Resected specimen showed a heterogenic tumor, 23 × 22 × 11 cm in diameter (d)
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tiple varying-sized cytoplasmic eosinophilic globules
were seen (Fig. 2a, b). Immunohistologically, tumor cells
were positive for vimentin (Fig. 2c), alpha 1-antitrypsin
(Fig. 2d), and alpha 1-antichymotrypsin (Fig. 2e), andFig. 2 Histological features of HE staining (×200, a; ×400, b) showed spind
Multiple varying-sized cytoplasmic eosinophilic globules were seen. Tumor
and alpha 1-antichymotrypsin (×400, e). The MIB-1 index was 20 % (×200, fpartially positive for alpha-smooth muscle actin (SMA)
and CD68/kp-1. S-100, calponin, cytokeratin, factor VIII,
CD34, and AFP were negative in tumor cells. The MIB-1
index was 20 % (Fig. 2f ). Finally, the tumor was histolog-
ically diagnosed as a UESL, and the liver parenchymaled, oval, or stellate tumor cells distributed in myxoid or fibrous stroma.
cells were positive for vimentin (×400, c), alpha 1-antitrypsin (×400, d),
)
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operation, for the sequential recurrent diseases, a left
caudate lobectomy and a partial hepatectomy of segment
3 were performed as the second and the third surgery,
respectively. Twenty months after the first operation,
twice transarterial chemoembolizations (TACEs) with
CDDP 50 mg + lipiodol 2.5 ml, epirubicin 30 mg, and
gelatin sponge were performed. Twenty-five months
after the first operation, a radio-frequency ablation (RFA)
was performed (pre, Fig. 3a, c; post, Fig. 3b, d). Thirty-
five, 42, and 47 months after the first operation, two
times of partial hepatic resections and a hepatectomy in
combination with RFA (pre, Fig. 3e; post, Fig. 3f ) were
additionally performed. Because of bone metastases and
tumor thrombosis in azygos vein, she unfortunately died
62 months after the initial hepatectomy.
Case 2
A 53-year-old female was admitted to our hospital with
a huge liver tumor with symptoms of epigastralgia and
back pain. Her HBs-Ag and HCV-Ab were negative.
Serum level of PIVKA-II was elevated to 10,369 mAU/
ml, and AFP, CEA, and CA19-9 were in the normalFig. 3 Three recurred tumors (arrows; a, c, e) were successfully treated witrange. CT showed a huge low-density tumor sized 18 ×
14 cm that showed mild enhancement after administra-
tion of contrast medium (Fig. 4a). MR imaging demon-
strated the heterogeneous tumor to be hypointense on
T1-weighted images (Fig. 4b) and hyperintense on T2-
weighted images (Fig. 4c). Some satellite lesions sus-
pected as cavernous hemangiomas were identified in the
bilateral lobe of the liver. The first extended left hepatec-
tomy was performed. Operation time was 459 min and
intraoperative bleeding was 877 g. Resected specimen re-
vealed a tumor with multiple components, sized 22 × 19 ×
14 cm (Fig. 4d). Histologically, spindled, oval, or stellate
tumor cells were distributed in myxoid or fibrous stroma.
Nuclear pleomorphism and hyperchromasia with frequent
multinucleated or bizarre giant cells were apparent. Mul-
tiple varying-sized cytoplasmic eosinophilic globules were
seen (Fig. 5a, b). The tumor cells were positive for vimen-
tin (Fig. 5c), alpha 1-antitrypsin (Fig. 5d), alpha 1-
antichymotrypsin (Fig. 5e), and desmin, and partially
positive for CD34 and alpha-SMA. The MIB-1 index was
30 % (Fig. 5f ). Hepatocyte specific antigen (HSA) and
cytokeratin were negative in the tumor. The tumor was
histologically diagnosed as a UESL in the normal liver.h radio-frequency ablations (arrows; b, d, f), respectively
Fig. 4 Computed tomography showed a huge low-density tumor sized 18 × 14 cm that showed mild enhancement (a). Magnetic resonance
imaging showed the tumor to be hypointense on T1-weighted images (b) and mixed hyperintense on T2-weighted images (c). Resected specimen
revealed a tumor with multiple components sized 22 × 19 × 14 cm (d)
Fig. 5 Histological features of HE staining (×200, a; ×400, b) showed spindled, oval, or stellate tumor cells distributed in myxoid or fibrous stroma.
Nuclear pleomorphism and hyperchromasia with frequent multinucleated or bizarre giant cells were apparent. Multiple varying-sized cytoplasmic
eosinophilic globules were seen. The tumor cells were positive for vimentin (×400, c), alpha 1-antitrypsin (×400, d), and alpha 1-antichymotrypsin
(×400, e). The MIB-1 index was 30 % (×200, f)
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Fig. 6 The recurred tumor (arrow, a) was successfully treated with radio-frequency ablation (arrow, b).
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80 mg + lipiodol 4 ml, 5-FU 1000 mg, and gelatin
sponge) was performed. Four and 14 months after the
first operation, a partial hepatic resection of segments 6
and 7 and a partial hepatic resection of segment 8 in
combination with RFA (pre, Fig. 6a; post, Fig. 6b) were
also performed, respectively. She is now alive without any
recurrent diseases for more than 65 months from the ini-
tial hepatic resection.
Conclusions
UESL in adult is extremely rare and the prognosis of
UESL patients is very poor [3, 4, 7]. Although the treat-
ment strategy of adult UESL is not well established, if
possible, liver resection and adjuvant chemotherapy are
recommended [7].
Two cases of adult UESL patients were occasionally ad-
mitted to our hospital in the same period. Instead of the
huge size of the tumors, both patients were successfully
treated with the initial hepatic resections. The first patient
survived 62 months with receiving a total six times of hep-
atic resection, twice RFAs, and two times of TACEs. The
second patient received three times of hepatic resection
and a TACE and RFA and is still alive more than 65
months from the initial treatment. Both patients received
no adjuvant chemotherapy or radiotherapy.
UESL has been reported to be chemotherapy-sensitive
or is highly sensitive to TACE [3, 7]. However, the re-
ported regimens of chemotherapy for adult UESL were
heterogeneous [7]. As systemic chemotherapy, sarcoma-
directed one such as vincristine, actinomycin, ifosfamide,
doxorubicin, carboplatin, or etoposide was often selected
for metastatic UESL [7]. In the current patients, TACE
was selected to treat the intrahepatic multiple recurrences
of the UESL. Sarcoma-directed chemo-drugs were not
established as the regimens of TACE, so a combination of
CDDP, epirubicin, and 5-FU was used [8]. In the current
two patients, TACE was not so effective; thereafter, re-
peated hepatic resections or RFAs were mainly selected.
Noguchi et al. reported a long-term survival case of
adult UESL treated with hepatic resection, adjuvant che-
motherapy, and additional radiotherapy [9]. They alsoreviewed the reported long-term survival cases of adult
UESL and discussed that complete resection is important
for ensuring long-term survival. In the treatment strategy
of liver tumors, the effectiveness of RFA as well as surgical
resection is widely reviewed [10]. To the best of our know-
ledge, there are no English reports of adult UESL treated
with RFA. In the current cases, four tumors treated with
RFA showed no recurrences at the therapeutic sites for
mean observation period of 35 months. RFA can be one of
the effective modalities to treat UESL, especially in cases
with multiple small intrahepatic recurrences. Repeated
hepatectomies and RFAs for the recurrent diseases may
influence such long survivals of the current adult UESL
patients.
In conclusion, although adult UESL is a rare and aggres-
sive malignancy, repeated hepatic resections and RFAs for
the recurrent diseases may provide a longer survival.
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